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ABSTRACT 
 
 
 This IQP describes the impact of stem cell technology on society.  The different 
types of stem cells including adult, embryonic, and cord, along with the medical potential 
each type.  The project concludes that although there is great potential with clinical stem 
cell therapies for curing disease and injuries, many legal and ethical obstacles need to be 
overcome for human ES cell therapies can be conducted. 
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EXECUTIVE SUMMARY 
 
In the human body, stem cells are known as the “master cells” of the body.  Stem 
cells are undifferentiated cells that can differentiate into other types of the cells in the 
body to perform a specific function, thus they are a very exciting new field for biological 
research because they are long-lived and can proliferate many times, and can be “coaxed” 
into differentiating into a type of cell needed to cure a disease. 
 There are three different types of stem cells in the body. Embryonic or ES cells, 
adult stem cells, and cord stem cells.  Adult stem cells are found in the body at any age 
but not in high quantity, while cord stem cells are found in the umbilical vein and the 
placenta. Cord cells are good to use because they offer less rejection by the human body, 
but the time in which they can be cultured in lab is short. The most promising type of 
stem cell is the ES cell which can be cultured for long amounts of time, and because it is 
completely undifferentiated it can be “coaxed” into differentiating into any type of cell 
needed for a given application.  ES cells offer the most medical potential, but since the 
gathering of these types of cells involves the destruction of an embryo, there is much 
controversy around their use. 
 Stem cells have become a very hot topic in the scientific fields because of their 
unbelievable potential in curing disease and helping heal the body. Of course one must 
put aside fantasy and concentrate on the reality of what has really been accomplished to 
date.  There will not be arms and hearts being grown in laboratories anytime soon. On the 
other hand, stem cell research has shown that clinical therapies involving both adult and 
ES cells can be used to treat and cure debilitating diseases such as Parkinson’s disease 
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and diabetes.  Research has shown that with the use of stem cells, the problem cells 
which cause these two fatal diseases can be repaired and thereby the patient cured. Stem 
cell therapies are also being developed to treat other health problems such as spinal cord 
injuries and damage to the heart done by heart attacks.  Currently the majority of stem 
cell therapies include the use of adult stem cells, but slowly ES stem cell therapies are 
being brought from animal experimentation into human clinical use.  
 With stem cells and their research being such a controversial topic, it is not 
surprising that there are ethical obstacles that stand in the way of research being done, 
particularly with ES cells. The real question or controversy surrounds the use of 
blastocysts to attain the ES cells.  Some call it murder, while some say a zygote is not a 
human being.  This is a question that has created a highly publicized ethical issue in this 
country and throughout the world.  Of the four major world religions, Christianity and 
Hinduism have a strong stance against the use of ES cells because in their doctrine life 
begins at conception and an embryo is considered life.  Judaism on the other hand has a 
slightly more lax view of life since it considers life to begin much later than a 5 day old 
blastocyst, but in reality there is no clear stance by Judaism on the issue of Es cells and 
therapeutic cloning.  Some jewish scholars agree with ES research, and some don’t.  
Islam is the only major religion that shows strong support for the use of ES cells. Muslim 
doctrine states that an embryo is not considered life until 120 days after gestation, 
therefore the use of embryos for research is not considered unethical. There are some 
however who believe only leftover embryos should be used and new ones should not be 
created just for attaining stem cells.  Of course each individual must make up their own 
mind.   
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 The other major obstacle in the way of ES cell research is the legality of the 
research itself.  After the discovery of ES cells in 1998, countries all over the world 
began implementing various statutes or restrictions because of the highly controversial 
way in which ES cells are attained.  In the U.S. for instance, up until 2001, research was 
barely restricted, but on August 9, 2001, President George W. Bush announced an 
executive order which allowed federal money could be spent only for research on stem 
cell lines created before that date. Of course private funding was still available and still 
continues today to offset federal legislation. Many states began overriding that executive 
order.  In 2001, California overrode the federal order and voters passed Proposition 71 
which created a 3 billion dollar ES cell research institute. Many states soon followed 
including New Jersey and Massachusetts.  There are still some states however who 
aligned themselves with the executive order and have banned ES cell research.  In the US, 
it almost became a “red state vs. blue state” issue.  With regards to the international 
community, European countries were also split on its stance on stem cells. The UK for 
instance allows therapeutic cloning in order to attain stem cells and is very lax, even 
offering compensation for women who donate embryos, but countries like Germany do 
not allow the research at all.  Whatever the case may be, most countries now have some 
kind of statutes or restrictions in place, some very progressive and other very 
conservative. The legality of ES cell research will continue to be a major obstacle in the 
way of truly realizing the potential stem cell therapies can offer. 
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PROJECT OBJECTIVE 
 
 
 
 The purpose of this IQP was to examine the controversial topic of stem cells and 
their effects on society.  Multiple stem cell categories and origins were investigated to 
show the reader that some stem cell research does not destroy embryos. Stem cell 
applications were analyzed to separate fact from fiction in this area, while ethics and 
legalities were also explained to demonstrate the full societal impact of this new 
technology. 
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CHAPTER-1:  STEM CELLS:  TYPES AND SOURCES 
 
What Are Stem Cells? 
Stem cells are the foundation cells for everything in your body. These are the cells 
that initially created your organs, tissues and other various cells your body requires.  In 
general, stem cells have three main characteristics.  First, these cells are long-lived.  They 
persist in vivo throughout a person’s life, and can divide in culture indefinitely. Second, 
they are the “master cells of the body”, with the potential to change into other cell types.  
Embryonic stem (ES) cells) can give rise to all types of cells, while adult stem cells 
usually can generate only the tissue from which they were isolated.   Thirdly, stem cells 
are unspecified cells, meaning they retain their primordial undifferentiated state, so are 
ready to differentiate into other cell types.  
When cells can replicate numerous times it is called proliferation. Most cells such as 
heart and nerve normally cannot proliferate. Because stem cells can proliferate without 
change they are often described as being capable of long-term self-renewal. To say that 
stem cells are unspecified or unspecialized indicates that they do not have any kind of 
“tissue specific” molecules that would allow them to carry out a specialized purpose. This 
means that while the stem cell cannot pump blood like heart muscle, it can give rise to 
heart muscle to carry out that function (National Institute of Health, 2005).  Basically, 
these are cells that haven’t decided what they want to be yet and some can be made into 
virtually any cell found in the human body.  These properties are why scientists are so 
excited about stem cells. They have the ability to cure life threatening diseases and the 
potential for even more, thus they are the basis for the new field of regenerative medicine.   
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Categorizing Stem Cells by their Locations  
There are three main categories of stem cells that are distinguished by where they are 
located:  adult stem cells, embryonic stem cells, and cord stem cells.   
 
Adult Stem Cells 
Adult stem cells are found in the tissues of adults.  But they are also found in children 
and fetal tissue. The term adult is used because it refers to the maturity of the organ that it 
is taken from (Johns Hopkins Medicine, 2006).  These stem cells are not found in large 
quantity however. This category of stem cells has not been found in all the vital organs. 
In the case of brain tissue adult stem cells are present, but are not very active. This results 
in a generally undetected response to a brain or spinal cord injury.  Also, adult stem cells 
are typically only able to generate tissue similar to the one they were isolated from 
(ISSCR, 2004.  An example of this are brain stem cells.  They are usually capable of 
generating only brain tissue.  A more complex example is bone marrow. Bone marrow 
stem cells can produce all the cellular components of blood, even though this includes a 
variety of cells such as red blood cells, several types of white blood cells, and platelets 
(ISSCR, 2004). 
 
Embryonic Stem Cells 
Embryonic stem cells are the inner mass of cells in a human blastocyst. About four to 
five days after fertilization the embryo is a hollow ball made up of approximately 150 
cells, the blastocyst, composed of the inner cell mass (ICM), and the surrounding cells 
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the trophoblast (ISSCR, 2004). Research on embryonic stem cells is still in its infancy 
due to the fact that they were first isolated in humans in 1998, while adult stem cell 
research has been ongoing since the 1960s (National Institute of Health, 2006).  Another 
potential source of embryonic stem cells are the germ cells of aborted fetuses. Embryonic 
germ (EG) cells are what develop into the egg and sperm cells. These cells show similar 
properties to ES cells when cultured, but there is also evidence that they may be limited 
in their capacity to produce a variety of cells due to the fact that the germ cells have 
developed for several weeks as opposed to five days. Although ES cells are the most 
important medically due to their ability to create a variety of tissues, because an embryo 
is usually destroyed to obtain them strong ethical issues surround their use.   
 
Cord Stem Cells 
Cord blood is the third known source of stem cells. These cells are collected from the 
umbilical vein and placenta after a child is born. This source is far more accessible 
compared to the other options since the cord is normally discarded at time of birth.  In 
addition, cord stem cells typically are rejected less by the patient, demonstrating less graft 
versus host disease.  However these stem cells can be cultured in a lab for a shorter 
amount of time than embryonic and adult stem cells (ISSCR, 2004). Cord blood banking 
has become more common in recent years. Today, it is quite easy to find a private or 
public cord blood bank to save and store this valuable material. Once harvested, the blood 
containing the stem cells is screened for infections and the tissue type is documented.   
The material then goes through processing, which involves removing the red blood cells, 
before being stored in liquid nitrogen. When a patient donates and uses his or her own 
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stem cells the treatment is called autologous. If the patient receives another donor’s stem 
cells the treatment is called allogeneic.  Receiving stem cells from your identical twin is 
referred to as syngeneic (Wikipedia, 2006).  To date, Viacord, a well-known cord blood 
bank, has performed nineteen successful transplants (Viacord, 2004). 
Recently, scientists have also found stem cells in baby teeth and the amniotic fluid 
surrounding the unborn baby. This discovery is very current but promising. More 
research must be done to determine the type of stem cell they are and find the full 
potential of these stem cells (ISSCR, 2004).   
 
Categorizing Stem Cell by Their Potentials 
Not all stem cells are created equally. While all types are important medically, some 
are better than others (Figure-1). Stem cells that have the potential to make any of the 216 
types of cells in the human body are called totipotent stem cells (upper cell in the 
diagram).  Totipotent cells are only found in newly fertilized eggs, called zygotes. It is 
these first few totipotent cells that will start to become specialized within days of 
fertilization and go on to form the approximately three trillion cells in the whole body. 
This is why totipotent cells are the most valuable (MedIndia, 2006)?  From totipotent 
stem cells come all the other stem cells (The Why Files, 2006).  
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Figure-1:  Stem Cell Potentials.  All stem cells are capable of self-
renewal (arrows to the left of each cell).  Totipotent cells (upper cell in 
the diagram) can create all cells in the body.  Pleuripotent cells (middle 
cell) can create several kinds of cells, while adult stem cells (lower right) 
usually generate only one type of cell.  Picture courtesy of The Why 
Files Guide to Stem Cells. 
 
 The next rank of stem cells as far as potency goes is pleuripotent stem cells. These 
stem cells can produce a very large variety of cell types, but cannot develop a human 
being.  Embryonic stem cells that were mentioned earlier are pleuripotent. Pleuripotent 
stem cells have the most potential medically speaking because they are more accessible 
and can still produce a myriad of tissue types (Wikipedia, 2006).  Figure-2 shows an 
image of a colony of pleuripotent stem cells. 
 
Figure-2:  A Photomicrograph of a colony of Pleuripotent ES Cells 
(University of Wisconsin-Madison, 2006). 
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Multipotent stem cells can make a few cell types, but not as many as pleuripotent. A 
good example of multipotent stem cells is hematopoietic stem cells (HSCs).  HSCs are 
found in a person’s bone marrow and in cord blood, and are responsible for making blood 
cells.  Bone marrow is found in the femurs, hips, sternum, and ribs primarily, the hips 
being the most common harvest site (Wikipedia, 2006).  HSCs are the reason why 
patients with certain cancers or blood diseases receive hematopoietic stem cell transplants 
(HSCT), more commonly called bone marrow transplants. HSCT were first performed by 
Dr. Donnall Thomas in the 1970s.  He was able to show that the HSCs are capable of 
repopulating the ill patients bone marrow and therefore produce new, healthy blood cells. 
This work later earned him a Nobel Prize (Wikipedia, 2006).   Figure-3 shows an image 
of bone marrow stem cells.  
 
Figure-3:  Micrograph of Bone Marrow Hematopoietic Stem Cells.  Image courtesy of  Leonard, 
Science Photo Library (2006). 
 
The last type of stem cells and the least variable are unipotent cells. These only have 
the ability to make one type of cell but are still capable of self-renewal, a feature unique to 
stem cells.  Two examples of unipotent stem cells are neuronal cells, which produce nerves, 
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and epithelial cells, that become skin cells.  Figure-4 left panel is an image of neural stem 
cells while the picture on the right is of epithelial stem cells found in the mammary gland. 
          
Figure-4:  Micrographs of Neural Stem Cells (left panel) and Epithelial Stem 
Cells (right panel).  Left image coutesy of Klaus Guldbrandsen/ Science Photo 
Library (2006).  Right image courtesy of Mammary Stem Cells, NSC Home Page 
(2006).  
 
 
 
Stem Cell Transdifferentiation 
 Although most adult stem cells are capable of only generating the tissue 
from which they were isolated, a recent theory, known as the “theory of stem cell 
plasticity”, was announced. This theory suggests that some adult stem cells may have a 
greater potential to form more varieties of cells than was previously thought, which 
would extend their reparative capabilities to other kinds of tissue (Mammary Stem Cells, 
2006).  For example, some scientists claim that culturing hematopoietic stem cells 
(HSCs) on a feeder layer of neuronal cells (that secrete neuronal growth factors) can 
change (transdifferentiate) the HSCs into neuronal cells. Transdifferentiation is a topic 
highly debated among scientists. Some claim that it does not occur at all naturally, 
however the evidence is mounting that cells can transdifferentiate.  In animal cases that 
involve missing parts being regenerated the evidence speaks for itself. A well-known 
example that occurs in salamanders and newts is the Wolffian regeneration. In this 
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experiment the lens of an eye was removed and subsequently a new lens forms from the 
dorsal iris. For this to happen the dorsal iris cells, which are naturally pigmented, must 
transdifferentiate into the characteristic transparent lens cells. While it’s amazing that 
salamanders and newts can transdifferentiate cells, the questions remains can humans do 
the same (Theory, 2006)?  Many laboratories are trying to perfect a way to convert tissue 
from the liver into pancreas tissue in humans.  If this process can be developed this 
therapy would be used to treat diabetes patients. This would be an enormous discovery 
considering there are approximately 150 million diabetes patients worldwide currently 
with that figure expected to double to 300 million over the next twenty years 
(Transdifferentiation, 2005).    
 
Stem Cell Isolation 
You might expect that since stem cells are so valuable they would be difficult to 
harvest, but the processes are relatively simple. As mentioned before, the best-known 
stem cell harvest procedure is a bone marrow transplant. Under local anesthetic the bone 
marrow is removed usually from the top of the hips of the donor using a syringe. The 
process is typically less than an hour in length, and any pain afterwards can be alleviated 
with over the counter medicine. The recipient will then receive the new bone marrow 
intravenously (Abbott, 2006).   A more recent option for purifying HSCs that does not 
involve bone marrow is called peripheral stem cell harvesting.  Peripheral HSCs are 
found in small numbers in a person’s veins. The donor is given medication in advance of 
the procedure to boost peripheral cell production thereby increasing the amount harvested 
per treatment. A needle is inserted into the donor’s arm and tubes lead the blood to a cell-
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separating machine to collect the stem cells.  From there the blood is delivered back into 
the patient through a different needle in the other arm. The process takes two days, five 
hours each day, to complete one session and involves little to no pain for the donor. In 
either HSC-harvesting procedure the stem cells can be transplanted immediately or 
frozen until needed (Abbott, 2006). 
Once stem cells have been harvested they can be grown in a laboratory. The cells 
are grown in cultures at 37 degrees Celsius and under high humidity. The factor that 
varies is what the cells are grown on in culture. Different stem cells thrive on different 
food, or medium. The ultimate goals of growing the cells are to be able to grow large 
amounts of cells that are unspecialized, and to be capable of making them specialize 
when desired (ISSCR, 2006).  Researchers at Yale University took it upon themselves to 
determine what the minimum nutritional requirements were to successfully grow human 
embryonic stem cells. The mixture, named HESCO, is reported to consist of a growth 
factor called Wnt3 and a basic fibroblast growth factor (bFGF).  Also in the mix are 
cholesterol, transferring (a plasma protein that transfers iron in the body), a B-cell 
activating factor, insulin, and albumin (the major protein in the clear fluid portion of 
blood) (Emanuel, 2006). Recently however, researchers at the University of Wisconsin-
Madison announced they had developed a way to successfully grow stem cells without 
the use of any animal cells for nourishment. Using this method the chance of 
contaminating the stem cell line with animal viruses and other undesired agents is 
eliminated. This in turn eliminates the risk of a patient receiving infected stem cells as 
part of their therapy (Devitt, 2006). 
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Human embryonic stem cells are moderately simple to grow in a lab. The cells grow 
on a layer of skin (epithelial cell feeder layer) and in the presence of serum. These 
provide the nutrients the stem cells require. If too many cells grow, some are transplanted 
to a different culture to continue growth. This process is called passaging and can be 
repeated forever in theory.  With respect to culturing, hematopoietic stem cells are the 
exact opposite of embryonic cells. They tend to become specialized very quickly and are 
very hard to grow in culture. For these reasons, hematopoietic cells are usually not grown 
in labs (ISSCR, 2006), although a local biotech company (Viacell Inc.) founded by a 
former WPI Biology and Biotechnology graduate student Morey Kraus, has had some 
success amplifying cord HSCs. 
Culturing neural stem cells is different in that they grow in suspension and not 
attached to the culture dish. They also do not require serum nutrients from blood. In 
culture, the neural cells grow to form a hollow ball called a neurosphere. Eventually the 
neural stem cells will develop into specialized cells (ISSCR, 2006). 
If the cells are successfully grown in vitro, meaning outside the body, a stem cell line 
is established. A stem cell line is defined as “a population of cells which can replicate 
autonomously for long periods of time”.  These stem cell lines must keep their ability to 
form specialized cells after they are removed from the lab conditions that keep them from 
differentiating otherwise they are no longer considered a line (MedIndia, 2006).  
Embryonic stem cells easily fit these rules. Currently in the U.S. there are about eight to 
ten stem cells lines that are widely accepted as valid embryonic stem cell lines (ISSCR, 
2006).  A subsequent chapter in this IQP will examine whether these few ES lines are 
sufficient for supporting the ES research effort in the U.S. 
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Therapeutic Cloning 
After understanding what a stem cell line is and how they work, you might be 
wondering how all of this relates to cloning. The honest answer is that working with stem 
cells is a form of cloning when it involves nuclear transfer.  It is very important to say 
here that this is not the cloning depicted in movies or science fiction! While some 
concepts in the films may include elements of truth, they are still just movies and fiction.  
There are two types of cloning: reproductive and therapeutic. Reproductive cloning is 
constructing a new individual from a single cell. This is accomplished by removing the 
nucleus in an egg and replacing it with the nucleus from another cell in the body. The 
nuclear transferred egg is then implanted in a surrogate mother to be carried full term, 
assuming all goes well (MedIndia, 2006).  In theory, the resulting offspring would be a 
clone of the adult whose genetic material was used.  In animals, the process has produced 
a large variety of transgenic animals that are useful medically, and has produced snuppy 
the worlds first cloned dog (Lee et al, 2005).  However the cloning process is not efficient, 
and many oocytes are required, and the offspring can experience many problems. About 
one percent of clones that survive are normal and free of health troubles. Reproductive 
cloning is very inefficient, difficult, and initially made for agriculture reasons, not human 
applications (ISSCR, 2006).  
Therapeutic cloning is the pertinent form of cloning for stem cell purposes. As with 
reproductive cloning, the nucleus of the embryo is replaced with one from another cell. 
For example, the goal is to take the nucleus from a patient’s skin cell and clone an 
embryo to obtain ES cells for treating the same patient. Early claims to have achieved this 
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from Hwang’s lab in South Korea (Hwang et al, 2005) were unfortunately withdrawn as 
fabricated.   The major difference between reproductive and therapeutic cloning is that in 
the latter the embryo is never implanted into a surrogate and is not expected to mature 
full term.  The goal of this therapeutic procedure is to obtain a blastocyst from which to 
isolate ES cells to repair damaged tissues (MedIndia, 2006). The chief benefit to this 
technique is the patient will not reject the stem cells because they are made of the same 
genetic material (ISSCR, 2006).  
 
Parthenotes 
Harvesting the embryonic stem cells by traditional methods involves destroying the 
blastocyst, which some consider murder.  A different option that does not involve 
destroying the zygote is parthenogenesis. This method uses chemicals to fertilize the egg 
instead of fertilization from a male.  Because partnenotes cannot produce viable offspring, 
their destruction creates fewer ethical considerations.  To date, parthenotes have been 
achieved from primates (Cibelli et al, 2002) and humans (Cibelli et al, 2001), but ES cell 
lines have not yet been achieved with human parthenote blastocysts.  This topic will be 
discussed further in Chapter-3 on Stem Cell Ethics. 
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CHAPTER-2:  STEM CELL APPLICATIONS 
 
Introduction 
When discussing the potential stem cells have in healing the sick, wounded, or 
diseased, one must always be careful not to intertwine what’s real and what’s hype. With 
stem cells, much of the problem has been that people, usually the media, hypes stem cells 
to be a cure for all ailments and issues. This in turn leads people to believe the wrong 
things about what stem cells can do.  
 The reality is that it is true that stem cells have amazing potential to cure many 
high profile and fatal diseases such as diabetes and Parkinson’s diseases, or to help 
regrow tissue and repair damage done to the nervous system. The mistake some people 
make is that they oversimplify how hard it is to extrapolate animal experiments to 
humans, and how hard it is to control the differentiation of the stem cells into desired 
tissues.  Some say we’ll just inject some stem cells, and eureka the disease is cured. This 
however is not the case, as stem cell therapies are only slowly being put into human 
clinical use. The main areas where stem cell clinical therapies are being made are in 
regenerative medicine, diabetes, Parkinson’s disease, and spinal cord injury, so each of 
these disorders will be discussed in this chapter. 
 
 Since the body is essentially a machine made up of parts which work together, 
one can theorize that it is possible to replace a faulty part with one that is as good or 
maybe even better than the original part. This where stem cells come into play.  Putting 
aside the nonsense of growing arms and eyes in a lab, the real work being done with stem 
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cells in regenerative medicine is at the cellular level. The theory behind this is that by 
using stem cells, either embryonic or adult, new tissue can be grown inside the body in 
place of any permanently damaged tissue.  
 
 
Stem Cells and Diabetes  
  
 One of the biggest potential applications of stem cells is in the fight to cure 
diabetes. In the U.S., diabetes kills an estimated 200,000 people a year, and is considered 
the seventh leading cause of death (Stem Cells and Diabetes, 2005).  Diabetes can affect 
any type of person, therefore combating it and fighting it is a hard process, which calls on 
one to constantly take medication, insulin shots and check their blood sugar periodically. 
Also leaving diabetes untreated can lead to a host of severe medical problems such as 
blindness, heart disease, and limb amputation from circulatory problems. 
 Currently there is no way to cure diabetes. Patients with Type I diabetes must 
inject insulin everyday, while those with Type II must take oral medication and be on a 
strict diet in order to control blood sugar levels. Some patients receive a pancreatic 
transplant which has shown promise, but because of the risky nature of transplant surgery, 
and the overall lack of pancreas organ supply, most diabetic patients must live day to day 
always taking care of themselves. With the discovery of stem cell therapies though, 
diabetic patients may have a chance at living a life where medications are not needed 
everyday to ensure a happy life. 
 Scientists and researchers have been going about creating stem cell therapies in 
many ways to combat diabetes using not only embryonic stem (ES) cells, but cells from 
adult and fetal tissue to reignite or restart a balanced insulin production. The research on 
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fetal tissue has not been as successful as the research done using adult and embryonic 
stem cells. In the case of fetal tissue, although results showed islet formation and insulin 
production, it was very difficult to expand the culture of the purified fetal cells, therefore 
logistically it was a hard therapy for normal clinical use (Beattie et al., 1997). 
 Adult stem cell therapies have shown great promise with regards to diabetes. 
Many different studies have been done with all different types of adult cells to reignite 
insulin production. One group of researchers actually isolated adult islet cells from 
cadavers and using genetic engineering, caused the functioning cells to proliferate into 
many insulin producing cells (Itkin-Ansari et al., 2001). Other researchers have been 
focusing on the ductal cells inside the pancreatic ducts. Several different teams of 
scientists have studied and experimented with these ductal cells and, through forced 
differentiation, have caused the proliferation of both more ductal cells, and insulin-
producing endocrine cells. Tests have shown that these new endocrine cells have been 
producing insulin at levels very near the ideal amount needed per amount of glucose 
present (Stem Cells and Diabetes, 2005).  However, one of the real problems with adult 
tissue is the fact that these new cells may form into tumors, but up until now, there has 
not been overwhelming evidence that this happens in the majority of cases. 
 With regards to embryonic stem cell treatment of diabetes, the initial thought was 
that diabetes could be cured in a day or two. This if course in unrealistic but the optimism 
is valid as embryonic stem cells could one day drastically reduce the effects of diabetes.  
Although the biggest problem with adult cell therapies and/or pancreatic transplant has 
always been whether or not the patient’s body would accept the new cells or would they 
fall victim to the immune system’s defenses, with embryonic stem cell therapies, the cells 
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can be engineered from the start to not induce any immune response. The other big 
advantage of embryonic stem cell therapies is that through the correct steps and correct 
engineering of the cells, brand new islets can be formed which would reverse the effects 
of diabetes. 
 Most of the research done on embryonic stem cell therapies of diabetes until now 
has involved animal experiments. Many research groups have used different types of 
engineering, and have all found that with some engineering, embryonic stem cells can 
differentiate into insulin producing cells (Assady et al.,  2005). The way in which they 
induce the differentiation can be different, but in the end many of the initial results show 
that insulin is being produced by these newly differentiated cells. 
 Although it may be years until there is a definitive stem cell therapy for treating 
diabetes, when digging through all the hype of the “magical two-day cure,” one can see 
that there is actually great promise, and that research is moving along quite rapidly 
towards an end all treatment for diabetes. Although there has been some success in the 
human trials for combating Type I diabetes using adult pancreatic cell transplants, the 
fact still remains that Type I diabetes is caused by an autoimmune problem. This creates a 
major obstacle for scientists as some therapies may work good for the short term but over 
the long term, scientists need to make sure that these newly transplanted cells are not 
killed off by the immune system.  
 
 
Stem Cells and Nervous System Disorders, Parkinson’s Disease 
 
The second major area where stem cell therapies have a potential of saving 
millions of lives and curing millions of people is in diseases and ailments of the nervous 
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system, such as Alzheimer’s disease and Parkinson’s disease. Up until very recently it 
was believed that brain cells and nerve cells could not easily regenerate, therefore any 
kind of damage to the brain and/or spinal cord was a permanent injury which could not be 
repaired.  Recently though new research is showing that some regeneration does occur, 
and with the advent of stem cells, that regeneration can be elevated to the point where 
new nerve cells and brain tissue can be born. 
 Parkinson’s disease is a disease, which affects a persons motor skills.  It is a 
neurodegenerative disease, which occurs when the dopamine producing cells in the brain 
die. When this happens dopamine is no longer produced, which causes severe impairment 
of motor skills since dopamine is the brain chemical, which allows for the smooth 
coordinated movement of the body to occur. Currently Parkinson’s affects about 1.5 
million people in the U.S., and every year thousands more are diagnosed (Rebuilding the 
Nervous System with Stem Cells, 2005). What is especially devastating about the effects 
of Parkinson’s, besides the tremors and impaired movement, is the slow onset of the 
effects, which can happen over a span of years causing one to have an altered life style.  
New stem cell therapies though have shown great promise in fighting and possibly even 
curing Parkinson’s. Currently there are three approaches being undertaken by researchers 
in creating stem cell therapies for treating Parkinson’s. They include tissue transplants, 
growing new neurons for implantation, and the reigniting of adult stem cells in the 
patient’s brain to enhance the body’s repair mechanism. 
 Fetal tissue transplants (containing neural stem cells) have been used since the 
mid 1980’s as many groups have tried to transplant fetal tissue in order to restart 
dopamine production in the brain (Rebuilding the Nervous System with Stem Cells, 
25 
2005).  Although many of these studies proved successful in that some of the transplanted 
dopamine producing cells did survive even after the death of the patient there was not 
enough dopamine produced to show a significant statistical difference (Rebuilding the 
Nervous System with Stem Cells, 2005).  Nevertheless, there was hope and promise that 
with the right type of engineering, these dopamine producing cells could be productive 
enough to reverse the effects of Parkinson’s.  
 The next major approach used with stem cells and Parkinson’s is the growing of 
new neurons from undifferentiated cells.  The theory is that if these new neurons are 
place in the brain, they will begin to produce a sufficient amount of dopamine needed for 
Parkinson to be reversed. Much of this line of work however involves using embryonic 
stem cells since they are the most undifferentiated stem cell known. Much of the research 
being done on this approach has yet to be completed but many groups have reported 
success so far with mouse and fetal embryonic stem cells (Freed et al., 2001).  Also one 
privately funded group, the Geron Corporation, has shown much success using human 
embryonic stem cells.  This group has shown results that they were able to coax human 
embryonic stem cells to form into mature neurons. Another group at the NIH also showed 
success in coaxing ES cells into becoming cells, which had the same behavioral and 
physiological characteristics as dopamine producing neurons (Kim et al., 2002). Of 
course these results are all in a laboratory setting, and the technology is probably years 
away from being ready for clinical use. Still there is much optimism that with the right 
engineering and methods, this type of stem cell therapy can be used to induce dopamine 
production and reverse the effects of Parkinson’s disease. 
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 The third major approach taken to combat Parkinson’s using stem cell therapies is 
to actually induce the patient’s own stem cells found in the brain to begin or restart the 
body’s natural repair mechanism. This approach is the most current of three discussed, 
and is barely into the research phase, but scientists believe that if they could control and 
or enhance the migration of one’s own stem cells into the damaged area by adding the 
appropriate growth factors, repair can begin sooner and can be more productive. It is 
known that when part of the brain is injured or impaired, stem cells migrate to the area 
(Rebuilding the Nervous System with Stem Cells, 2005). What scientists want to do is 
possibly merge approaches 2 and 3, and use adult or embryonic stem cells to further 
enhance this intra-patient migration and allow for real repair of the damage. This type of 
approach may also be useful not only in treating Parkinson’s, but any kind of injury that 
affects the nervous system, even paralysis due to spinal cord injury. 
 Much of the work done with Parkinson’s research seems to be more focused on 
using embryonic stem cells which offer the most potential since completely 
undifferentiated cells are needed, but when it comes to treating other injuries which affect 
the nervous system such as spinal cord injuries, scientists have actually put a lot of 
emphasis on adult stem cells, since they are available and can be used clinically. With 
spinal cord injuries, the difficulty seen is that many neurons are destroyed, therefore 
reconnecting these neurons to begin sending messages again is very hard.  But what stem 
cells can provide is partial healing, at least for now, which would allow some semblance 
of movement. 
 Many different types of techniques are being used to treat spinal cord injuries 
with adult stem cells. Usually the process involves taking one’s own adult stem cells and 
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re injecting them into the wounded area.  For example a patient who had severe spinal 
cord injury was injected with stem cells from his own olfactory bulbs (Hughes, 2005). 
Soon he was able to gain some movement and control of the bladder. Of course with the 
rapid research in embryonic stem cells, one can be sure that embryonic therapies will also 
be developed which can possibly allow for even more healing than with adult stem cells, 
but that remains to be seen (Stem Cell Treatment, 2004). As of right now, adult stem cell 
treatments are being clinically used and have shown great success in allowing people to 
move and in some cases walk again. 
 
Stem Cells and Heart Disease 
 
 The third major pathology area where stem cell therapy research is occurring is in 
the field of heart disease.  One of the fast moving areas of regenerative medicine using 
stem cell therapies is in reversing the damaging effects of heart disease and/or heart 
failure. Heart failure affects about 5 million people in the U.S.  Heart failure is basically 
caused by an inability of the heart to pump sufficient blood, usually caused by damaged 
cardiomyocytes (Can Stem Cells Repair a Damaged Heart, 2005). This damage usually 
occurs from heart attacks or other heart conditions. When these cells do not work 
properly, the body cannot be supplied with the blood needed for one to survive.  Patients 
usually die within a few years.  Although treatments are currently available to combat 
congestive heart failure, such as drug therapies and mechanical assistance, in the end they 
are only temporary, and the condition continues to remain fatal.  Recently though new 
stem cell therapies have shown promise in allowing for the repair of these damaged 
cardiomyocytes and thereby almost curing the problem of a “weak heart”. 
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 The most current studies on repairing these damaged heart cells involved the use 
of adult stem cells or hematopoietic stem cells.  As seen below in Figure-1, these adult 
stem cells are injected into the heart and cause the differentiation and birth of new 
cardiomyocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure-1: Diagram of the Injection of Stem Cells into the Heart.  “Can Stem 
Cells Repair a Damaged Heart” (2005) NIH, Stem Cells, Chapter-9.   
http://stemcells.nih.gov/info/scireport/PDFs/chapter9.pdf 
 
  
With the induction and introduction of these adult or hematopoietic stem cells into the 
heart, the stem cells differentiate into healthy cardiomyocytes, which can restore function 
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to the damaged part of the heart (Hematopoietic Stem Cells, 2005).  This therapy has 
been shown to be very successful in rodent models and currently is being used in some 
places as a clinical therapy. In Germany for instance, a study done using 28 heart attack 
patients in 2003 showed much promise in using hematopoietic stem cells to induce 
cardiac regeneration (Britten et al., 2003). Each of the patients received his or her own 
hematopoietic stem cells into their hearts about 5days after the patient had suffered a 
heart attack. 26 of the 28 patients showed improved pumping efficiency and decreased 
dead tissue.  This study showed that these stem cell therapies can work clinically but the 
procedure needs to be improved upon in order for the heart top return to its normal 
efficiency.   
 In the US, these same types of trials are occurring as well in order to gain an 
understanding of how and why these stem cells cause heart tissue regeneration. In 2003, a 
17 year old who had his heart damaged from a nail gun accident was given an 
experimental treatment using an injection of his own stem cells in order to regenerate the 
damaged heart tissue. The experimental procedure was a success, and it was considered a 
victory for the stem cell community (Philipkoski, 2003).  In 2005, The University of 
Pittsburgh Medical Center began a trial similar to the one done in Germany involving 
heart attack patients and the use of stem cells to help heal their damaged hearts however 
the results have yet to be produced (Novel Stem Cell Trial, 2004).  Also in 2004-2005 
researchers at the University of California, San Diego (UCSD) School of Medicine 
discovered specialized stem cells found in the heart of newborns (Rare Heart Stem Cells, 
2004). Further research is needed to see what the full potential of these stem cells is, but 
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scientists predict that with the right type of environment and stimuli, heart stem cells can 
grow to become fully mature heart cells. 
 
Other Stem Cell Applications 
Aside from the research done in heart tissue regeneration, more research is being 
done on the regeneration of many other types of tissue using stem cells and tissue 
engineering. Since stem cells are a type of master cell in theory, they can differentiate 
into any type of cell in the body, which makes its potential even more grand. Of course 
when one thinks of regeneration, they get an idea of growing an entire arm out of a few 
cells, which is an unrealistic goal. The goal of the research being done now is to 
incorporate the regenerative properties and opportunities stem cells offer with the 
biomedical and tissue engineering work being done to allow for the growth of new skin 
tissue for example which resembles actual human skin instead of the biomedically 
engineered grafts available on the market.  
The real research being done on regenerative medicine seems to be done in 
private sector as slowly companies are combining the power of privately funded stem cell 
research with the most recent advances in medical devices and implants which will not 
only prolong life, but actually repair damage. For instance a company in Lincoln, RI, 
called Nephros Therapuetics created a device called the RAD which consists of a 
bioartificial tube lined with stem cells which differentiates into the cells which line the 
renal tubules and performs the same functions as a kidney (Glaser, 2003). Tests showed 
that when this implant was put into place it took the place of injured tubules, and allowed 
them to heal naturally without any interruption of normal kidney function. Other similar 
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therapies are being created as well.  Researchers at the University of Pittsburgh are 
working on a therapy to take stem cells from a patient’s eye and create an engineered 
ocular surface (Glaser, 2004). This could go a long way in providing a treatment for those 
with severe eye injuries. There is much more potential for using stem cells in 
regenerative medicine, such as in the liver and other organs, but these are all progressing 
slowly since there is still so much to be understood about the stem cell, how it works and 
how much work they can do. Even more recently, with the successes that stem cell 
therapies are producing, companies are offering to bank the stem cells found in a new 
mother’s umbilical cord blood, which can later be used if any stem cell therapy is needed 
on the child (Viacord, 2002; Viacell, 2002). 
 
Chapter Conclusion 
Stem cells obviously offer an amazing amount of potential in all of the fields 
discussed and in many more. The main point one needs to understand is how to separate 
the reality of this potential from the fantasy.  In five years scientists will not be able to 
grow appendages or entire organs in a laboratory, but they may be able to use stem cells 
to help heal neurons damaged from a spinal cord injury to allow for some use of one’s 
legs or arms. Stem cells offer amazing potential in allowing real healing to occur in the 
body. With the incorporation of stem cells with the current biomedical and tissue 
engineering research being done, there maybe be even more of a potential for stem cells 
in healing and regeneration of the body. 
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CHAPTER-3:  STEM CELL ETHICS 
 
Just because we know how to do something, doesn’t mean it is necessarily right. 
Some people know how to steal a car, but they don’t because they know its wrong. There 
are many who know how to use a gun, but they don’t shoot others because it is against 
the law. But what if you’re being attacked and you need to save your life?  Do you still 
shoot the person? What if a scientist was studying how to use stem cells and it could save 
hundreds of lives, but it involved destroying embryos that have the potential to become 
individuals?  The research could save many lives and improve the quality of life for even 
more.  If that embryo is a life, do you destroy it to save another life?  These are the 
questions we have to ask ourselves as this new frontier in medicine continues to open. 
How far are we willing to push the moral envelope, and at what cost?  Every person has 
their own opinion based on their morals and what they perceive as right and wrong. Many 
of our morals are taught to us based on our religious beliefs. This chapter will explore 
how the four major religions of the world view stem cell research and what position each 
takes.  It must be stressed that the opinions of one religious leader cannot be mistaken for 
the opinions of every follower associated with them. 
The benefits that stem cells present are numerous and promising. Scientists 
believe stem cells may be effective therapies or even cures to several diseases including 
diabetes, heart disease, liver disease, muscular dystrophy, Alzheimer’s disease, 
Parkinson’s disease, spinal cord injuries, and stroke. The list goes on, and may continue 
to grow as we learn more about the capabilities of stem cells (Potential, 2005).  
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 As an example of a recent stem cell application, just recently, scientists at the 
University of California, Los Angeles AIDS Institute and the Institute for Stem Cell 
Biology and Medicine were able to able to genetically manipulate an embryonic stem cell 
into a T-cell. T-cells are one of the body’s main defenses against disease and infection. 
This is a dramatic breakthrough for the treatment of blood diseases, including human 
immunodeficiency virus (HIV) and AIDS, acquired immunodeficiency syndrome, 
diseases that specifically target T-cells (Stem Cell Research Raises Hopes, 2006). While 
this is a tremendous breakthrough using embryonic stem cells, there are drawbacks that 
surface with stem cell research. 
The positives to stem cell research are abundant and provide strong emphasis for 
doing good things for mankind, but there are also several drawbacks. One of these is the 
lack of variability in adult stem cells.  Because the use of adult stem cells does not 
destroy an embryo, such cells have fewer ethical considerations, and all four main 
religions support their use so long as they are used to better mankind.  However such 
cells have less medical potential than ES cells because they can only generate the same 
kind of tissue they were isolated from.   Because researchers have yet to find a way to 
expand the variability of adult stem cells (i.e. they can not induce their trans-
differentiation into another type of tissue), the emphasis is shifts to embryonic stem cells, 
which in theory can generate any tissue in the entire body.  The greatest drawback to 
using embryonic cells is of course destroying embryos or obtaining the cells from aborted 
fetal tissue. While some people feel that this is necessary step in order for the greater 
good to benefit, others see destroying the embryos as murder, and therefore should be 
against the law.  This then leads to questions like: when does an embryo become a 
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person, and what rights does the unborn embryo have?  There is no one right answer to 
these questions, but some kind of compromise has to be met. That is possibly the only 
way the benefits of stem cell research can be accessed while minimizing the drawbacks. 
 
Christian Stance on ES Cells 
Christianity is currently the largest religion worldwide, boasting 2.1 billion 
members or approximately 33 percent of the world’s religious followers (Major Religions, 
2005). Christianity is a “one god” religion based on the teachings of Jesus of Nazareth 
that were recorded in the Gospels (Christianity, 2006).  Christian religion accepts the use 
of adult stem cells under the condition that they are only used for benevolent purposes.  
In his speech to the Diplomatic Corps Pope John Paul II stated, “…research using adult 
stem cells, moreover, offers the promise of considerable success (Pope John Paul, 2005).”  
The Christian concern is the use of embryonic stem cells.  Most Christians believe 
that life begins at the moment of conception.  Before forty days and before birth, a fetus 
has a soul and is entitled to the same rights as an adult. As quoted in the Holy Bible, from 
John the Baptist, “For he will be great in the sight of the Lord, and he will drink no wine 
or liquor; and he will be filled with the Holy Spirit, while yet in his mother's womb (Luke 
1:15).” This clearly explains that a fetus has a soul prior to birth. While it is not stated 
directly, other excerpts from the Bible suggest that ensoulment occurs at conception.  
Therefore, to destroy a blastocyst (day-5 embryo) intentionally and with premeditation, 
even for the benefit of the masses, constitutes murder in the eyes of most Christians, 
especially the Catholics (Shannon, 2006).    
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Parthenotes are also not approved by Christian religion.  In 1987 the Church’s 
Magisterium condemned parthenogenesis in the Instruction Donum vitae; words that “set 
forth the central content of Gods revelation and the sacredness and inviolability of human 
life (Dios, 2000).” While this approach cannot produce a viable human embryo, and 
therefore murder is not committed, Christianity is extremely opposed to human embryo 
manipulation. The bottom line here is that the Christian faith is opposed to all forms of 
research involving human embryonic stem cells (Cheshire, 2003).  It should be noted 
however, that Christianity encompasses many divisions. The views may vary between 
divisions, say from Catholic to Protestant. Catholics agree with the aforementioned 
policies while some Protestants think that its okay to use embryos “that cannot be used 
for reproductive purposes, within a 15-day window from fertilization (General, 2006).”  
Healing is greatly encouraged in Christianity. In the Bible there is a passage from 
the gospel of Matthew saying, “News about him spread all over Syria, and people 
brought to him all who were ill with various diseases, those suffering severe pain, the 
demon-possessed, those having seizures, and the paralyzed, and he healed them (Matthew 
4:24).” This begs the question, if remaining embryos from IVF are going to be discarded 
anyway, should they instead be used to heal, as Jesus did?  Not all Christians are opposed 
to embryonic stem cell research (Faithful, 2005). Some Christians, like members of the 
Christian Alliance for Progress and similar organizations, support embryonic stem cell 
legislature as well as other controversial topics (i.e. equality for gays/lesbians and 
abortion) (Issues, 2006).     
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Hindu Stance on ES Cells 
Hinduism has an estimated 900 million followers worldwide, making it the third 
largest religion in the world, as well as being the oldest religion on earth (Major 
Religions, 2005). Like Christianity, Hinduism teaches, “Conception is the beginning of a 
soul’s rebirth from a previous life,” and therefore marks the beginning of personhood 
(General, 2006). Thus it stands to reason that Hindus reject the use of embryonic stem 
cells as Christians do. This also includes obtaining stem cells from aborted fetuses. The 
dilemma Hindus face is where to draw the line between right and wrong.  Hindu 
teachings say to do good actions in the world, but they also say to respect the holiness of 
creation (Hinduism, 2006). Do the benefits of healing the ill outweigh the negatives of 
destroying embryos?  Each person and their interpretation of Hindu teachings can only 
answer this question.  
 Hinduism clearly supports the use of adult stem cells as long as they are taken 
with consent and used morally. According to a top Hindu spiritual leader, “Any 
knowledge can be used or misused. Atomic power can be used for the benefit of mankind, 
or it can be misused to destroy mankind with atomic bombs.  The only issue is how it is 
being used (Dharma, 2003)." Adult stem cells present a feasible alternative to ES cells in 
the Hindu faith as long as they are not misused.  
Hinduism considers another ethical side to stem cells: the fiscal aspect. Hindu 
scriptures say that followers should take notice to how money is earned. The focus should 
be on helping others and not increasing wealth.  A concern with stem cell therapy is that 
it will be too expensive and only be afforded by the rich, and the focus may shift to greed 
(Manickavel, 2006). This is a real concern considering that President George Bush 
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restricted federal funding for research in the US while India, where about 890 million 
Hindus live, is becoming a major biotechnology power.  If the possibilities of stem cells 
turn out to be realities, many people stand to gain a lot of money (Mishra, 2005).  So 
despite accepting adult stem cells as an alternative, the other ethical dilemma is whether 
or not the considerable financial gains of some are good for the soul. 
 
Muslim Stance on ES Cells 
  Islam is the next largest religion in the world after Christianity, having roughly 
1.3 billion followers (Major Religion, 2006). Islamic supporters, called Muslims, are 
guided by a central religious text called the Qur’an. The angel Gabriel delivered the 
Qur’an, or Koran in English, from God to the prophet Muhammad. The Shari’ah is the 
portion of the Koran that contains the legal text (Islam, 2006). As far as stem cell 
research goes, the Islamic faith is arguably the biggest supporter.  Two key excerpts 
appear in the Koran that support stem cell research. The first, 
 “We created (khalaqna) man of an extraction of clay, then 
we sent him, a drop in a safe lodging, then We created of 
the drop a clot, then we created of the clot a tissue, then We 
created of the tissue bones, then we covered the bones in 
flesh; thereafter We produced it as another creature. So 
blessed be God, the best of creators (klaliqin) (Weckerly, 
2006)!” 
  
This statement, explaining the creation of man, is important because of the phrase 
“thereafter We produced it as another creature.” It is interpreted to mean that the fetus is 
not seen as an actual life until later on in the pregnancy. Under Islamic law, an embryo is 
not considered a person but is acknowledged as potential life.  Actual life is given more 
protection than potential life.   Potential life becomes actual life after 120 days of 
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pregnancy, well after the blastocyst stage from which ES cells are derived.  This is 
described in the Koran in the excerpt,  
 
“Each of you possesses his own formation within his 
mother’s womb, first as a drop of matter for forty days, 
then as a blood clot for forty days, then as a blob for forty 
days, and then the angel is sent to breathe life into him 
(Weckerly, 2006).” 
 
 These two passages from the Koran are interpreted to mean that an embryo is not 
a human life until after 120 days of gestation and therefore it is not an infringement of 
Islamic law to use embryos in stem cell research (Weckerly, 2006). 
While Islamic law allows research on stem cells, there are some concerns held by 
Muslim scholars. One fear is that just because it is acceptable to destroy embryos for 
research, scientists may create the embryos for the sole purpose of destroying them. A 
solution is to only use frozen embryos left over from in vitro fertilization, provided the 
owners give full consent. Also, some kind of “monetary safeguards” should be set when 
compensating the donors; for example: donors can release the embryos to researchers 
with no compensation, or choose to have them eliminated from storage. This ensures that 
no embryo donor can receive money for the donation, eliminating money as a motivation. 
In addition, some Muslim scholars believe that there should be a limit to how many 
embryos are created. This would prevent excessive amounts than needed being created in 
hopes they would be donated.  Lastly, it is recommended that adult stem cell research 
continue in hopes that science will progress to the point where embryos are no longer 
needed (Siddiqi, 2002). 
 As with every religion, these are general rules and do not apply to every Muslim. 
Inevitably, some may feel stem cell research is wrong, while others may want to do more 
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to aide researchers.  It is important to realize that the opinions of some people are not the 
opinions of all people. 
 
Judaism Stance on ES Cells 
 Judaism is the smallest of the four major world religions, comprised of roughly 15 
million followers (Major Religions, 2006).  Jewish followers obey laws and 
commandments revealed to them by God in the form of the Torah. The Torah contains 
613 laws, of which only about 300 are still applicable today (Judaism, 2006). When the 
issue is stem cells, one can find laws that both support and discourage stem cell research. 
Once again, there is no dispute over the use of adult stem cells or cord blood.  The 
problem is with embryonic stem cells and those obtained from aborted fetal tissue 
(Jakobovits, 2006).  
 Until the fetus is born, the mothers life takes precedence, and if threatened, 
aborting the pregnancy is not considered criminal.  So in this case, actual life takes 
precedence over potential life.  However, aborting a fetus due to unwanted pregnancy or 
to obtain stem cells to save someone else is not allowed. Some believe that abortion 
violates the law of hurting oneself, while others say it defies the law of “wasting seed” 
(Eisenberg, 2006).  
 Another aspect to consider is that Jewish law clearly states that prior to forty days 
gestation a fetus lacks humanity.  In relation to abortion, rabbis vary in their opinion. 
Some say it violates the law because it was not a threat to the mother’s life, while others 
disagree arguing it was not entitled to the rights of a person yet, and is therefore not 
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murder. Some rabbis do not even justify the forty-day mark because it would violate 
wasting male seed, which is forbidden before conception occurs (Melman, 2001). 
Because there isn’t an official Jewish statement concerning the use of embryos in 
stem cell research, opinions vary.  Some believe that embryos left over from in vitro 
fertilization and genetic screening may be used in research that may lead to saving many 
lives.  In regards to creating embryos for the sole purpose of destroying them and using 
the stem cells, once again there is no official response (Eisenburg, 2006). It must be 
stressed once again that these opinions are not unanimous and do not represent the 
opinions of the Jewish community as a whole, just some of its leaders.   
 
Chapter Conclusions 
While the opinions of some religious leaders appear to be close-minded or too 
capricious, we may now have a better understanding of what their views are grounded in. 
It appears that the Christian point of view and the Islamic point of view will never come 
to a total agreement, but the most one can hope for is that everyone comes to some 
compromise.  For example, a good compromise would be to agree that adult stem cells 
should be used instead of ES cells whenever possible.  There will always be some who 
completely disagree with that future compromise, but that is to be expected (it is 
impossible to please all at one time). When you realize the immense numbers of people 
suffering from disease and genetic disorders that could be alleviated or cured, you 
understand that a compromise must be made for their sake; to end their suffering. 
Assuming that all we think stem cells can do is correct or even better, the outcome may 
outweigh the sacrifices.  Because there is no single clear conclusion that unifies the 
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religious stance on stem cells, perhaps in the end it boils down to individual consent, and 
working towards the common good.  The authors of this IQP think that adult stem cells 
should be used instead of ES cells whenever possible, and that research funding should 
be substantially increased for adult stem cell research.  We also think that excess embryos 
in fertility clinics are an acceptable source for ES cells (after all they are going to be 
destroyed anyway), so long as both parents provide consent, no money was paid to the 
donors, and the embryos were not created exclusively for stem cell purposes. 
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CHAPTER-4:  STEM CELL LEGALITIES 
 
Introduction 
With any new medical or scientific technological advancement, there are always 
obstacles that must be overcome, whether they are technological, ethical or legal.  In the 
case of stem cells, as we have seen the first two clearly apply, and maybe the biggest 
obstacle remaining is the legality of stem cell research. Although lawmakers in almost 
every country in the world understand the power that stem cells offer, the issue remains a 
very controversial one.  The reality is that lawmakers have not necessarily outright 
banned stem cell research, but lawmakers in many countries have setup guidelines and/or 
restrictions on federal funding for this type of research. 
 As discussed before, ES cells are probably the most advantageous of the three 
types of cells due to their ability to make almost all other kinds of cells. Although their 
discovery was fairly recent, 1998, the advancements already made, and their potential for 
further advancements has opened up the legal floodgates. Since most ES cells are 
gathered from embryos created through in vitro fertilization, the ethical issues discussed 
earlier have also become legal issues.  Lawmakers are basically forced to make a 
distinction of when life actually begins, and act on it.  If lawmakers believe that life 
begins before day-5 when ES cells are obtained from an embryo, then obtaining ES cells 
constitutes “murder”. These controversial issues surrounding stem cells have forced 
lawmakers to impose certain restrictions on federal funding for laboratories which derive 
ES cells.  Certain countries and/or regions of the world offer different ideas. Some 
European countries for instance, particularly Scandinavian countries, are more liberal or 
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progressive when it comes to supporting ES cell research knowing the end result may 
save hundreds of millions of lives, while other countries, due usually to major ethical or 
religious reasons, are very conservative about stem cell research.  Figure 1 below shows a 
color coded map of the world along with an explanation of colors showing which areas of 
the world are liberal about stem cell restrictions and which are very restrictive or 
conservative.  
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Map Explanation 
• "permissive" = various embryonic stem cell derivation techniques including somatic 
cell nuclear transfer (SCNT), also called research or therapeutic cloning. SCNT is the 
transfer of a cell nucleus from a somatic or body cell into an egg from which the nucleus 
has been removed. [Options 4 & 5 in Walters, LeRoy, in References, below] Countries 
in this category include the United Kingdom, Belgium, Sweden, Iran, Israel, India, 
Singapore, China, Japan, South Korea, South Africa, and others. [Walters, LeRoy, 
National Academy of Sciences, Oct. 12, 2004. See References, below] These countries 
represent a global population of more than 2.7 billion people.  
• "flexible" = derivations from fertility clinic donations only, excluding SCNT, and often 
under certain restrictions. [Option 3 in Walters, LeRoy, in References, below: "Research 
is permitted only on remaining embryos no longer needed for reproduction."] Countries in 
this category include Australia, Brazil, Canada, France, Spain, The Netherlands, Taiwan 
and others.  
• Restrictive policy or no established policy. Restrictive policies range from outright 
prohibition of human embryo research, to permitting research on imported embryonic 
stem cell lines only, to permitting research on a limited number of previously established 
stem cell lines. Countries with a restrictive policy include (among the most restrictive) 
Austria, Ireland, Norway, Poland, (among the less restrictive) Germany, Italy, and the 
United States.  
• Map is designed to reflect national policy and whether or not public funds may be used 
to pursue stem cell research using IVF embryos donated from fertility clinics. 
Figure 1: World Map Color Coded For ES Stem Cell Policy. 
(Hoffman, 2005) 
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The United States Stem Cell Policy 
 The U.S. has always been considered front runners in medical and scientific 
advancements, and it was no surprise that when ES cells were first discovered in the U.S. 
many private and public research institutions pledged much of their time and money to 
investigating the possibility that these ES cells could be used and manipulated to cure 
diseases such as diabetes and Parkinson’s.  Unfortunately with all this excitement over 
these new medical possibilities, the legal and political webs began to form in the country. 
Many conservative groups considered the destruction of embryos as illegal and unlawful, 
while liberal groups stated that an embryo is not alive, and were normally discarded 
anyway. 
 These political lines were drawn almost as soon as the potential of these newly 
discovered ES cells were announced. Since the issue was one of much social importance, 
soon it made its way to the Washington DC where lawmakers began discussing all 
matters relating to the embryos and how they were to be used.  
 As the development of ES cells began in the late 1990’s, Congress felt it needed 
to act immediately to setup some kind of guideline for federal funding towards this new 
technology.  In 1995, the Dickey Amendment was passed which called for federal funds 
not to be awarded to ES cell research where human embryos were either injured or 
destroyed (Stem Cell Laws 2005).  In its original form, the Dickey Amendment was 
really a law passed only for embryo research, but in 1998 when the first ES cells were 
isolated from embryos, the wording on the law was changed to only prohibit funding for 
research which directly causes embryo injury or death. This slight amendment to the law 
allowed for more research to be done with these newly discovered ES cells. 
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 More amendments were on the way but were put on hold when the newly elected 
Bush administration decided to take some time and “review” the issue.  In 2001, 
President George W. Bush announced that federal funding would be allowed for ES cell 
research on stem cell lines created before August 9, 2001, but none for lines created after 
that date (White House 2001).  This was a major compromise since it protected the 
further destruction of embryos while still allowing research to be performed on existing 
ES cell lines. At first this seemed like a very good thing for the community but soon it 
was realized that the existing cell lines were not as plentiful as originally thought, 
therefore the act actually slowed the fast paced advancement of U.S. ES cell research 
(Stem Cell Laws 2005). What basically happens now is if one wants to do research, they 
would need to check with the stem cell registry at the NIH to get funding for research and 
must prove that the line being used was created before the August 9 date (NIH 2005). 
 President Bush also created in 2002 the Council on Bioethics whose purpose was 
to discuss and assess matters regarding stem cell research, the ethics behind the research 
techniques, etc.  At first, the council was fairly balanced with both those for and against 
stem cell research, but in 2004, two of the council members were replaced with the 
staunchest advocates of restriction free stem cell research. 
 The stem cell issue was brought up again in 2005 and 2006 when both the House 
and Senate passed a bill, which eased restrictions on stem cell funding. The bill was 
actually a three-part bill, which called for federal funding for stem cell harvesting from 
embryos left over from in vitro fertilizations.  The second part made it illegal to grow 
embryos specifically for stem cell harvesting, and the third part called for more research 
to be done using umbilical and adult stem cells. Unfortunately the first part of this bill, 
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which may be the most important part, was vetoed by President Bush.  The issue remains 
unresolved as to whether Congress will actually obtain enough votes to overturn the veto 
(Stem Cell Controversy 2006). 
 
 
States Stem Cell Policies 
Some states in the United States are in the process of passing laws that override 
the federal funding restriction on newly created ES cell lines. There are also some states 
that abide by the federal law or are even more conservative in that they completely forbid 
research on embryos.  
 Some of the more “liberal” states, which have laxed laws against stem cell 
research, include California, Connecticut, Massachusetts, New Jersey and Rhode Island. 
These states have laws for instance, which allow the cloning of embryos for research. 
Also in these states, state funding is available for stem cell research (Johnson 2005).   
California was the first state to override the 2001 federal legislation. In 2004, voters 
approved Proposition 71, which created a 3 billion dollar publicly funded institute for 
stem cell research (LAO 2004).  Unfortunately the full amount of money has yet to be 
granted due to legal delays.  In 2004, New Jersey appropriated state funds for research in 
both embryonic and adult stem cells. Massachusetts, Connecticut and Maryland all 
followed suit and passed laws appropriating fund for stem cell research. Most of these 
states have also setup Research centers and/or institutes to further research all types of 
stem cells. 
 There are however some states which are not in favor of stem cell research. For 
instance Missouri does not allows the use of state funds for reproductive cloning 
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(although reproductive cloning is not used to obtain ES cells), and Nebraska law does not 
allow state funds to be used for ES cell research.  Other states such as Indiana do allow 
stem cells research from a placenta or amniotic fluid, but does not allow research on 
embryos and completely forbids cloning.  It seems as though with some states being in 
favor of embryonic stem cell research and some being against it, the issue of saving lives 
has become a political one, where the “red states vs. blue states” issue is also being pulled 
into the debate (Johnson 2005).  
 
European Policy on Stem Cells 
 European countries have always had the reputation of being more progressive in 
research, specifically research related to saving lives. The standards and or obstacles that 
European products have to pass are much less stringent that those of the FDA in the US. 
When it comes to stem cells though, there appears to be a large separation in which some 
countries have very permissible policies on ES cell research, while some have very 
restrictive policies which all but outlaw ES cell research of any kind or at least research 
where the cells have been harvested from destroyed embryos. 
 The most permissive countries in Europe include the United Kingdom, Belgium 
and Sweden. The UK has been very progressive about its policies with regards to ES cell 
research.  In 2001 it passed an addition to The Human Fertilization and Embryology Act 
which had originally been passed in 1990 to deal with IVF treatments (The Human 
Genome 2002). The 2001 addition allowed for the creation of embryos solely for research 
and examination, thereby legalizing therapeutic cloning.  It is illegal however for this 
newly created embryo to be implanted into a woman for reproductive cloning.  Even now 
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in 2006, the UK acts as a progressive beacon for stem cell research.  Recently the 
government has allowed women to donate some of their unused eggs during the IVF 
process for research, and in return they receive a discounted rate from the clinic for its 
services (New Scientist 2006). 
In Sweden the same permissive situation exists, where it is completely legal to 
therapeutically clone embryos for the sole purpose of harvesting ES cells (Sweden’s Stem 
Cell Success 2002).  Also other countries such as Singapore and Israel are slowly trying 
to become the stem cell giants that Sweden and UK are.  With very little political debate 
in these countries about morals or ethics, the new research is really breaking ground on 
possible treatments using these stem cells.  Some European countries are not completely 
permissive of cloning, in Spain and France for instance eggs no longer needed for 
reproduction can be used to create stem cell lines, but eggs themselves cannot be 
collected for the sole purpose of therapeutic cloning. 
While Sweden and the UK act as progressive countries that have put aside 
political squabbles to get this new technology moving, there are still many European 
countries that are staunchly against the legalization of therapeutic cloning. Countries like 
Poland, Austria and Norway are extremely restrictive allowing almost no stem cell 
research, not even on cell lines that were previously established, while countries like 
Germany and Italy have restrictive policies similar to the U.S. where only a certain 
number of established cell lines can be used for research and no therapeutic cloning can 
be newly performed (Kim 2002). Germany and Italy are very vocal about their stance 
against therapeutic cloning going so far as almost blocking the European Union from 
giving any funding for stem cell research (Deutsche Welle 2006). These restrictive 
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countries did have a small victory though as the EU awards funding on a case-by-case 
basis. 
The legal challenges that face stem cell research, specifically embryonic stem cell 
research don’t seem like they will end any time soon. With such a controversial way of 
attaining ES cells involving the destruction of embryos, one can always imagine that 
there will be some kind of resistance, but it seems as though slowly some states are 
becoming more and more progressive in understanding the importance of this research. It 
may a long time before any kind of common ground is found, but what is known is that 
this is a topic that will be discussed in legal circles and legislatures for many years to 
come. 
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CONCLUSIONS 
 
The ultimate goal of this IQP is neither to convince nor dissuade readers about the 
potential of stem cells, but to give them the knowledge and facts to form and defend their 
own opinions.  Hopefully some readers now know that some types of stem cells come 
from adults and do not destroy embryos to obtain them so are not opposed to that type of 
stem cell therapy, the difference between therapeutic and reproductive cloning, and 
recognize parthenotes as an alternative ES cell therapy.  
Another of our objectives was to dismiss any myths or fantasies surrounding stem 
cell applications. While Hollywood and the media portray this research to be incredible 
and able to make copies of limbs, organs, or even whole people, the viewer must 
remember that what they are watching is fiction combined with a shred of fact. With 
enormous amounts of animal research and human clinical testing, stem cells may allow 
victims of spinal cord injuries to use their limbs and perhaps walk again. Growing them a 
brand new limb or spine is not currently possible. We also tried to shed light on the 
reasons why some religions allow or forbid certain types of stem cells. Understanding a 
person’s beliefs could ultimately lead to acceptance and tolerance. Once again, it is 
important to remember everyone associated with a particular religious group may not 
hold the same beliefs.   
Lastly, we hope to have clarified the legal status regarding stem cell research, 
documenting which countries have lenient policies, which countries have moderate 
policies, and which countries do not allow any form of ES cell research. While some 
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readers may still be opposed to this research, the authors of this IQP feel it is in the best 
interest of society to support stem cell research through federal funding. In order to do 
this however the current U.S. policy regarding ES cells must be less restrictive, and allow 
new ES cell lines to be derived.  If these steps are not taken, it is our opinion that the U.S. 
will fall behind dramatically in this field of medical advancement.  As said before, these 
are our personal opinions. It is not our aim to persuade everyone to agree with us, but to 
educate people and allow them to make their own decisions. Being ignorant or 
misinformed is no longer an excuse.  
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